Syringomyelia-subarachnoid space shunt tube

By designing a combined H-shaped syringomyelia-subarachnoid shunt, the problems of obstruction and spinal cord compression caused by the unsealed end of the T-shaped shunt were solved, achieving both convenience and safety in the surgery.

CN120837820APending Publication Date: 2025-10-28THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511271097.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-09-08
Publication Date
2025-10-28

AI Technical Summary

Technical Problem

The existing T-shaped shunt tubes are not sealed at the end, which can easily cause blockage of the tube and put pressure on the spinal cord tissue when changing direction, posing a potential danger.

Method used

A combined syringomyelia-subarachnoid shunt was designed, which adopts an H-shaped structure, including an implantation part and an exit part, both of which are provided with sieve holes and sealed. It is equipped with an adjustable second component to change the shape, avoid compressing the spinal cord tissue, and prevent tissue debris from entering.

Benefits of technology

It achieves convenience and safety in surgical implantation, avoids tube blockage and spinal cord tissue compression, adapts to different spinal cord cavity wall thicknesses, and improves the safety and effectiveness of the surgery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120837820A_ABST
    Figure CN120837820A_ABST
Patent Text Reader

Abstract

The invention discloses a syringomyelia-subarachnoid space shunt tube, and relates to the technical field of syringomyelia surgery, the syringomyelia-subarachnoid space shunt tube comprises a first assembly and a second assembly, the first assembly comprises an embedding part and a leading-out part, the embedding part is communicated with the interior of the leading-out part, and the embedding part is fixedly connected with the leading-out part; sieve holes are formed in the embedding part and the leading-out part, and the end parts of the embedding part and the leading-out part are closed; and the second assembly can be sleeved on the surface of the lead-out part to change the shape of the first assembly. By arranging the second assembly, the h-shaped shunt tube is formed after combination, surgical implantation is facilitated, meanwhile, stress is prevented from pressing peripheral spinal cord tissue when the tube is bent, the position of the second assembly is adjustable, the second assembly can be individually placed according to the thickness of a syringomyelia wall, in addition, the tail end of the tube is closed, sieve holes are formed, and tissue debris is prevented from entering the tube to cause blockage.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of surgical technology for syringomyelia, specifically to a syringomyelia-subarachnoid shunt. Background Technology

[0002] Surgical treatment for syringomyelia involves draining the fluid from the cavity in the center of the spinal cord into the subarachnoid space, allowing it to be absorbed naturally. Currently, there are no dedicated syringomyelia-subarachnoid shunts available domestically or internationally. Traditional surgical treatments for syringomyelia involve draining the fluid from the cavity into the abdominal or thoracic cavity. Internationally, there are specialized T-shaped shunts with an open end, allowing the fluid from the cavity to be drained into the nearby subarachnoid space. Therefore, some physicians have modified T-shaped shunts for use.

[0003] However, the existing T-shaped shunt tubes are not sealed at the end. If tissue debris flows in, it can easily cause blockage. Moreover, the straight tube design can put pressure on the adjacent spinal cord tissue when the tube needs to change direction, posing a potential danger. Summary of the Invention

[0004] This invention provides a syringomyelia-subarachnoid shunt tube, which, when assembled, forms an H-shaped shunt tube, facilitating surgical implantation. It also avoids stress on surrounding spinal cord tissue when the tube bends. The tube end is sealed and has sieve holes to prevent tissue debris from entering and causing blockage. This addresses the problems of existing T-shaped shunt tubes, where the end is not sealed, debris easily causes blockage, and the tube exerts pressure on adjacent spinal cord tissue when changing direction.

[0005] The present invention provides the following technical solution: a syringomyelia-subarachnoid shunt tube, comprising a first component and a second component, wherein the first component comprises an implanted part and an exit part, the implanted part and the exit part are internally connected and fixedly connected;

[0006] Both the embedded part and the lead-out part are provided with sieve holes, and the ends of the embedded part and the lead-out part are closed.

[0007] The second component can be fitted onto the surface of the lead-out portion to change the shape of the first component.

[0008] As a preferred embodiment of the present invention, the lead-out portion is fixed in the middle of the embedded portion, and when the second component is not fitted onto the surface of the lead-out portion, the first component is T-shaped.

[0009] As a preferred embodiment of the present invention, the embedded part has two closed ends, the lead-out part has one closed end, and all three closed ends are passivated.

[0010] As a preferred embodiment of the present invention, the embedded part is provided with two sieve holes, which are respectively located near the two closed ends, and the lead-out part is provided with one sieve hole, which is located near the closed end.

[0011] As a preferred embodiment of the present invention, each of the sieve holes is provided with multiple holes, and they are arranged in a ring array.

[0012] As a preferred embodiment of the present invention, the second component is an arc-shaped tube structure.

[0013] As a preferred embodiment of the present invention, the second component has an arc of 90°, and after being fitted onto the surface of the lead-out portion, the first component is h-shaped.

[0014] As a preferred embodiment of the present invention, the length of the embedded part is 20mm, and the length of the second component is 30-40mm, based on the extension direction of the lead-out part when the second component is not fitted onto the surface of the lead-out part.

[0015] As a preferred embodiment of the present invention, the inner diameter of the first component is 1 mm and the outer diameter is 1.5 mm.

[0016] As a preferred embodiment of the present invention, the inner diameter of the second component is 1.6 mm.

[0017] Compared with the prior art, the present invention provides a syringomyelia-subarachnoid shunt tube, which has the following characteristics:

[0018] Beneficial effects:

[0019] By setting a second component, the assembled tube becomes an H-shaped shunt, which facilitates surgical implantation and avoids stress on the surrounding spinal cord tissue when the tube is bent. The position of the second component is adjustable and can be customized according to the thickness of the spinal cavity wall. In addition, the end of the tube is sealed and has sieve holes to prevent tissue debris from entering the tube and causing blockage. Attached Figure Description

[0020] Figure 1 This is a schematic diagram of the structure of the first component of the present invention.

[0021] Figure 2 This is a cross-sectional view of the lead-out portion of the first component of the present invention.

[0022] Figure 3 This is a schematic diagram of the structure of the second component of the present invention.

[0023] Figure 4 This is a schematic diagram of the combined structure of the present invention.

[0024] In the diagram: 1. First component; 101. Embedded part; 102. Lead-out part; 2. Second component; 3. Screen hole. Detailed Implementation

[0025] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0026] See also Figures 1-4 This invention discloses a syringomyelia-subarachnoid shunt, comprising a first component 1 and a second component 2. The first component 1 includes an implanted portion 101 and an exit portion 102. The implanted portion 101 and the exit portion 102 are internally connected and fixedly connected. Both the implanted portion 101 and the exit portion 102 are provided with sieve holes 3, and the ends of the implanted portion 101 and the exit portion 102 are closed.

[0027] The second component 2 can be fitted onto the surface of the lead-out portion 102 to change the shape of the first component 1.

[0028] It should be noted that the first component 1 is made of medical-grade silicone, which is soft and easy to bend. The second component 2 is made of medical-grade plastic and provides support and protection when the first component 1 is bent, preventing the bend from being compressed and sealed. The position of the second component 2 is determined based on the thickness measurement of the syringomyelia wall.

[0029] Specifically, the lead-out portion 102 is fixed to the middle of the embedded portion 101. When the second component 2 is not fitted onto the surface of the lead-out portion 102, the first component 1 is T-shaped. The length of the embedded portion 101 is 20mm. Based on the extension direction of the lead-out portion 102 when the second component 2 is not fitted onto the surface of the lead-out portion 102, the length of the second component 2 is 30-40mm. The inner diameter of the first component 1 is 1mm, and the outer diameter is 1.5mm.

[0030] The embedded part 101 has two closed ends, the lead-out part 102 has one closed end, and all three closed ends are passivated.

[0031] In this implementation scheme, the passivation treatment of the closed end can prevent unnecessary puncture damage to surrounding tissues.

[0032] Specifically, the embedded part 101 is provided with two sieve holes 3, which are respectively located near the two closed ends, and the lead-out part 102 is provided with one sieve hole 3, which is located near the closed end. Multiple sieve holes 3 are provided at each location and are arranged in a circular array.

[0033] In this implementation scheme, the ends are all passivated and sealed, and have sieve holes 3 to prevent broken tissue from entering the pipeline and causing blockage.

[0034] Specifically, the second component 2 is an arc-shaped tube structure with an arc of 90°. After being fitted onto the surface of the lead-out portion 102, the first component 1 is H-shaped. The inner diameter of the second component 2 is 1.6 mm.

[0035] In this embodiment, the assembled whole is h-shaped, such as... Figure 4 As shown. The device is implanted during surgery. The straight segment, shaped like the letter H, is implanted into the syringe of the spinal cord, which is the implantation part 101. The curved segment is brought out through the syringe, and the end of the extraction part 102 is implanted into the subarachnoid space.

[0036] In summary, this syringomyelia-subarachnoid shunt, by incorporating a second component 2, forms an H-shaped shunt after assembly, facilitating surgical implantation and preventing stress on surrounding spinal cord tissue when the tube bends. Furthermore, the position of the second component 2 is adjustable, allowing for personalized placement based on the thickness of the spinal cavity wall. Additionally, the tube end is sealed and has sieve holes to prevent tissue debris from entering the tube and causing blockage.

[0037] It should be noted that, in this document, terms such as "comprising," "including," or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such a process, method, article, or apparatus. Without further limitation, an element defined by the phrase "comprising one..." does not exclude the presence of other identical elements in the process, method, article, or apparatus that includes said element.

[0038] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.

Claims

1. A syringomyelia-subarachnoid shunt, characterized in that, It includes a first component (1) and a second component (2). The first component (1) includes an embedded part (101) and an exit part (102). The embedded part (101) and the exit part (102) are internally connected and fixedly connected. Both the embedded part (101) and the lead-out part (102) are provided with sieve holes (3), and the ends of the embedded part (101) and the lead-out part (102) are closed. The second component (2) can be fitted onto the surface of the lead-out portion (102) to change the shape of the first component (1).

2. The syringomyelia-subarachnoid shunt tube according to claim 1, characterized in that: The lead-out part (102) is fixed in the middle of the embedded part (101). When the second component (2) is not fitted on the surface of the lead-out part (102), the first component (1) is T-shaped.

3. The syringomyelia-subarachnoid shunt tube according to claim 1, characterized in that: The embedded part (101) has two closed ends, the lead-out part (102) has one closed end, and all three closed ends are passivated.

4. The syringomyelia-subarachnoid shunt tube according to claim 2, characterized in that: The embedded part (101) is provided with two sieve holes (3), which are respectively set near the two closed ends. The lead-out part (102) is provided with one sieve hole (3), which is respectively set near the closed end.

5. The syringomyelia-subarachnoid shunt tube according to claim 3, characterized in that: Each of the sieve holes (3) is provided in multiples and arranged in a ring array.

6. The syringomyelia-subarachnoid shunt tube according to claim 1, characterized in that: The second component (2) is an arc-shaped tube structure.

7. The syringomyelia-subarachnoid shunt tube according to claim 2, characterized in that: The second component (2) has an arc of 90°. After being fitted onto the surface of the lead-out part (102), the first component (1) is h-shaped.

8. The syringomyelia-subarachnoid shunt tube according to claim 1, characterized in that: The length of the embedded part (101) is 20mm, and the length of the second component (2) is 30-40mm, based on the extension direction of the lead-out part (102) when the second component (2) is not fitted on the surface of the lead-out part (102).

9. The syringomyelia-subarachnoid shunt tube according to claim 1, characterized in that: The inner diameter of the first component (1) is 1 mm and the outer diameter is 1.5 mm.

10. The syringomyelia-subarachnoid shunt according to claim 1, characterized in that: The inner diameter of the second component (2) is 1.6 mm.